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Abstract: 
Background: Patients with coronary heart disease often suffer from an impaired Health-Related Quality of Life 
(HRQoL). Several studies suggest that a healthier lifestyle does not only extend individuals’ length of life but might also 
improve their HRQoL. The aim of this study was to explore the relation between lifestyle changes and HRQoL in 
European coronary patients.  
Methods: Data on 8745 coronary patients, from 22 countries, participating in the EUROASPIRE III survey (2006-2007) 
were used. These patients hospitalized for coronary artery bypass graft (CABG), percutaneous coronary intervention 
(PCI), acute myocardial infarction (AMI) or myocardial ischaemia, were interviewed and examined at least 6 months 
and no later than 3 years after their hospital admission to gather information on their HRQoL, lifestyle changes and 
risk factors.  
Results: Significantly better HRQoL scores were found in ex-smokers compared to current smokers. Patients who 
made an attempt to increase their physical activity level had a better HRQoL compared to those who had not made an 
attempt. Furthermore dietary changes were associated with HRQoL, with better outcomes in patients who tried to 
reduce fat and salt intake and increase fish, fruit and vegetable intake. The intention to change behavior was not 
associated with HRQoL. 
Conclusion: Our analyses add support to the idea that coronary patients adopting a healthier lifestyle after their 
coronary event -by smoking cessation, adopting a healthier diet or increasing their physical activity- have significantly 
better HRQoL scores compared to those who did not alter their behaviour. 
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Introduction: 
Even though cardiovascular disease (CVD) mortality rates have fallen rapidly in many European countries in the latest 
decades, CVD continues to be the number one cause of morbidity and mortality (1;2). Many risk factors contribute to 
the development of CVD. In addition to unchangeable risk factors like age, family history, gender and geographical 
area, the progress of CVD is driven by several modifiable risk factors (3). Unhealthy lifestyle habits such as smoking, 
physical inactivity and unhealthy eating habits have a major influence on the development of CVD, hence guidelines 
on CVD prevention have stressed the importance of adopting a healthy lifestyle both in high risk patients as well as in 
CVD patients (2;4-7).  
Several studies in the general population indicate that the uptake of a healthier lifestyle - such as smoking cessation, 
becoming physically active and developing healthy eating habits - will not only extend the length of life but also 
improve the health-related quality of life (HRQoL) (8-10). HRQoL is a comprehensive concept referring to the 
individual’s physical, emotional and social well-being (11). Coronary patients often suffer from an impaired HRQoL, 
hence many of them consider HRQoL equally important as the length of life. Patients and their caregivers as well as 
policy makers have a particular interest in finding ways to improve patients’ overall well-being (11). However, 
evidence regarding the direct association between lifestyle changes and HRQoL in coronary patients is scarce. Some 
studies report on the association between HRQoL and smoking cessation, weight loss or physical activity, however to 
our knowledge, no study had investigated the association of lifestyle changes in coronary patients with various HRQoL 
measures in a systematic manner (12-17). 
The aim of our study was to explore the relation between different lifestyle changes and HRQoL in coronary patients 
using data from a large European cohort. Knowledge about the impact of lifestyle changes on HRQoL outcomes may 
be important in motivating patients to change their behavior. Moreover, the outcomes of this study can be important 
for decision makers in defining priorities related to their prevention policy. We hypothesized that coronary patients 
who did not make an attempt to change their behavior in order to adopt a healthier lifestyle would have a poorer 
HRQoL. 
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Methods 
Study population and data collection 
This study is based on data collected during the EUROASPIRE III survey (European Action on Secondary and Primary 
Prevention through Intervention to Reduce Events). Details of the study have been described extensively elsewhere 
(18). Briefly, the EUROASPIRE III survey, conducted during 2006-2007 under the auspices of the European Society of 
Cardiology-Euro Heart Survey Programme, was a cross-sectional study to determine whether the European 
recommendations on CVD prevention were being followed in everyday clinical practice across 22 European countries 
(76 hospital centres): Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Finland, France, Germany, Greece, Hungary, 
Ireland, Italy, Latvia, Lithuania, Poland, Romania, Russian federation, Slovenia, Spain, The Netherlands, Turkey, and the 
United Kingdom. Patients aged between 18 and 80 years, hospitalized for coronary artery bypass graft (CABG), 
percutaneous coronary intervention (PCI), acute myocardial infarction (AMI) or myocardial ischaemia but without 
evidence of MI -hereafter referred to as the recruiting diagnosis- were retrospectively identified from diagnostic 
registers, hospital discharge lists or other sources. In total, 8,966 patients (participation rate=73%) were interviewed 
and examined at least 6 months and no later than 3 years after their initial hospital admission. The present study 
included only those patients for which HRQoL info was available (n=8745). 
Data collection was conducted by trained research staff using standardized methods and instruments. Patient medical 
records from the initial hospital admission were reviewed, to collect -among others- information on their initial 
diagnosis, waist circumference, body weight and height.  At the time of interview and examination (on average 1.24 
years after the recruiting diagnosis) physical measurements were performed in light indoor clothes without shoes 
using calibrated measuring equipment. In addition, information was obtained on risk factors and adopted lifestyle 
changes.  
During the interview, data were gathered on smoking history and smoking cessation attempts undertaken since the 
initial hospital admission. Likewise, information on dietary steps (reducing salt intake, reducing or changing fat intake, 
increasing fish intake, increasing fruit and vegetable intake) taken since the initial hospital admission to eat healthier 
and to reduce their body weight were collected. Additionally, several questions were asked regarding patients’ 
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physical activity level. Patient were asked to describe their self-perceived physical activity level on the following scale: 
no physical activity; light physical activity; vigorous physical activity for 20 minutes, 2 or 3 times a week; or vigorous 
physical activity for 20 minutes ≥ 3 times a week. Additionally, they completed the short form International Physical 
Activity Questionnaire (IPAQ) allowing the categorization of patients according to their physical activity score. In 
addition, information about their future intention to change was gathered. 
Body mass index (BMI) was calculated as the patients’ weight in kilogram divided by the squared height in meters. The 
WHO classes were used for classification: normal range was defined as a BMI <24.9 kg/m²; overweight was defined as 
a BMI between 25 and 29.9 kg/m² and obesity as a BMI ≥30 kg/m² (19). Central obesity was defined as waist 
circumference ≥102 cm in men and ≥88 cm in women (20). Smokers were those who reported to be a current smoker 
or who had a carbon monoxide in breath value exceeding 10 ppm at the time of the interview. IPAQ classes were 
calculated according to the guidelines for data processing and analysis (21). A low IPAQ score was defined as no 
activity or some activity reported but not enough to meet the other categories. A moderate IPAQ score was defined as 
3 or more days of vigorous-intensity activity of at least 20 minutes per day, or 5 or more days of moderate-intensity 
activity and/or walking of at least 30 minutes per day, or 5 or more days of any combination of walking, moderate-
intensity or vigorous intensity activities achieving a minimum total physical activity of at least 600 MET-minutes/week. 
MET or Metabolic equivalent is a common outcome measure used to express the energetic expenditure of different 
physical activities (22). A high IPAQ score was defined as vigorous-intensity activity on at least 3 days and 
accumulating at least 1500 MET-minutes/week or 7 or more days of any combination of walking, moderate- or 
vigorous- intensity activities accumulating at least 3000 MET-minutes/week. 
 
To assess patients’ HRQoL, three self-administered questionnaires were used: the EuroQoL-5D (EQ-5D), the 12-item 
short form health survey (SF-12v2) and the Hospital Anxiety and Depression Scale (HADS). Though it should be noted 
that the latter does not fully meet the HRQoL definition, since the measure merely covers psychological issues. 
Questionnaires were administered in the countries’ official language. Validity of these scales in this sample has been 
reported previously (23). 
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The EQ-5D contains a self classifier using 5 dimensions, with 3 response categories each, to assess patients’ health 
status: mobility, self-care, usual activities, pain/discomfort and anxiety/depression; from which an EQ-5Dindex score can 
be calculated (with 1 representing perfect health, 0 representing death, and <0 representing a health state perceived 
worse than death). In addition, patients were asked to indicate their current health status on a visual analogue scale 
(EQ-VAS) ranging from 0 (worst imaginable) to 100 (best imaginable) (24). The current analyses only makes use of the 
VAS, as the normality assumptions for the EQ-5Dindex were not met. 
The SF-12v2 is a shortened version of the SF-36 consisting of 12 Likert scale questions, covering 8 dimensions: general 
health, physical functioning, role-physical, bodily pain, vitality, social functioning, role-emotional and mental health. 
Both physical (PCS-12) and mental functioning (MCS-12) component scores, ranging between 0 and 100, were 
calculated using a common scoring algorithm, with lower scores representing worse and higher scores representing 
better health (25). The SF-12v2 was not administered in Hungary.  
The HADS contains 7 items related to anxiety and 7 to depression, each with a 4-point response scale. Item scores can 
be added to obtain the summary scores on anxiety (HADS-A) and depression (HADS-D) separately. The total score on 
each subscale ranges between 0 and 21 with higher scores representing worse outcomes (26). 
Statistical analyses 
All analyses are based on generalized linear mixed models in order to account for the clustering of patients within 
countries. HRQoL differences between groups were tested using multiple linear regression models. Potential 
confounding caused by differences in age, gender, diagnostic category, education, cardiovascular history and diabetes 
was adjusted for all models. Results are shown for men and women together, since the interaction term with the 
different items was non-significant. Significance levels were set at p<0.05. All statistical analyses were performed 
using the IBM SPSS statistical software (version 20.0). 
 
Results 
The main characteristics of the patients included are shown in table 1. Data on 6523 men (74.6%) and 2222 women 
(25.4%) were available for analyses. Patients’ mean age was 63.2 years (SD=9.5). At the time of the recruiting 
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diagnosis, patients’ mean BMI was 28.3 kg/m2 (SD=4.4 kg/m2), 30.5% of patients were obese, 44.9% were central 
obese and 30.2% reported smoking. At the time of the interview, patients’ mean BMI was 28.9 kg/m2 (SD=4.5 kg/m2), 
35.4% were obese, 16.9% were still smoking and 11.7% reported no physical activity.  
In those patients being overweight or obese at the time of the recruiting diagnosis, 77.0 % reported ever being offered 
weight advice by a doctor or health professional, 68.2% of all patients reporting having ever received personal advice 
on increasing physical activity, 92.0% had been ever advised on a healthy diet, and 87.7% of patients smoking at the 
time of the recruiting diagnosis had been ever offered smoking advice. 
Since the recruiting diagnosis, 81.8% of smokers made an attempt to quit smoking in order to reduce their risk of 
recurrent coronary heart disease, 90.2% of patients tried to eat healthier by reducing salt, sugar or fat intake and 
increasing fish, fruit and vegetable intake, 63.6% of patients being overweight or obese at the time of the recruiting 
diagnosis made an attempt to lose weight and 58.6% of patients took steps to increase their physical activity level. 
SMOKING 
HRQoL scores were significantly worse in smokers compared to non-smokers, with ex-smokers (both patient who 
stopped smoking before or after the recruiting diagnosis) having HRQoL values leaning towards the scores of never 
smokers (Table 2). Patients who had made an attempt to quit smoking since the recruiting diagnosis, had a better 
HRQoL score (HADS-D, EQ-5Dindex, EQ-VAS, PCS-12) compared to those who did not undertake an attempt to quit. 
However, as can bee seen from table 2 the smoking status at the time of interview was responsible for these HRQoL 
differences. Indeed, whether or not a cessation attempt was made had no impact on the HRQoL outcomes in those 
still smoking at the time of the interview. A closer look into the quitters’ HRQoL indicated that the time since smoking 
cessation (<6 months vs. >6months) did not have an influence on their self-perceived mental, physical and overall 
well-being. Patients still smoking at the interview, who had the intention to quit smoking in the following 6 months did 
not differ in HRQoL scores from those who did not think about quitting.  
PHYSICAL ACTIVITY 
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Patients who had made an attempt to increase their physical activity had a better HRQoL compared to those who did 
not make an attempt (table 3). The actual physical activity level reported during the interview was significantly 
associated with HRQoL. A positive relation between HRQoL outcomes and the amount of exercise was seen both with 
the results of the validated IPAQ instrument as well as with the results of a single question, asking about the patients’ 
self-perceived physical activity level. A combined parameter including IPAQ class and increasing physical activity 
revealed significant differences across groups, with the lowest HRQoL in those in the lowest IPAQ class not making any 
attempt to become physically active, whereas those having a moderate or high IPAQ level who declared to have made 
an attempt to increase their physical activity had the highest HRQoL. At interview, in patients with a normal weight 
not yet exercising regularly, no significant difference was found in HRQoL -except for PCS-12- between those willing to 
become physically active, versus those not willing to become physically active. In contrast, patients being overweight 
or obese at interview with the intention to exercise regularly in the near future had a higher HRQoL compared to 
those with no intention to become regularly physically active.  
BODY WEIGHT AND HEALTHY DIET 
BMI was significantly associated with HRQoL, with obese patients having inferior HRQoL outcomes (Table 4). At 
interview, among patients who were still overweight or obese, those with the intention to lose weight in the 
upcoming months did not differ significantly in HRQoL (except for PCS-12) from those who did not have any intention 
to lose weight. With regard to actual weight change, no significant difference was found in HRQoL (except for PCS-12) 
outcomes between those who had lost weight (≥5% weight loss), maintained their weight level (-5% <weight 
change<+5%) or gained weight (≥5% weight gain) between the recruiting diagnosis and the interview. HRQoL differed 
significantly between those who had taken steps to adopt a healthier diet, compared to those who did not. Patients 
reducing fat intake, reducing salt intake, increasing fish intake or increasing fruit and vegetable intake had higher 
HRQoL values, however the effects on the psychological dimensions was sometimes non-significant (MCS-12, HADS-A). 
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Discussion 
The aim of the current study was to investigate the relationship between lifestyle changes and HRQoL in coronary 
patients, using a large cohort originating from 22 European countries. Our analyses add support to the idea that 
coronary patients who adopt a healthier lifestyle after their coronary event - by smoking cessation, developing 
healthier eating habits or increasing their physical activity - have significantly higher HRQoL scores compared to those 
who did not alter their behaviour, even after adjustment for other patient characteristics.  Furthermore, no significant 
differences were found in HRQoL outcomes between patients thinking about smoking cessation versus those not 
intending to quit. Hence these results reject the idea that those willing to quit smoking may have had a higher initial 
HRQoL allowing them to find the motivation to quit.  Though these results should be interpreted with caution since 
ex-smokers might differ from current smokers in several unmeasured characteristics. Likewise, overweight or obese 
patients considering weight loss versus those with no intention to lose weight did not differ in HRQoL outcomes. 
Regarding physical activity, in patients with a normal body weight, no differences were found between those with the 
intention to become more regularly physically active, versus those with no intention. For overweight and obese 
patients on the contrary, those who have the intention at interview to become more physically active have a higher 
HRQoL. Not surprisingly, the greatest HRQoL differences were found in the items capturing the current physical health 
status. After all, physical activity constitutes a component of HRQoL. Patients experiencing problems with their 
physical health, due to pain for instance, may be less likely to become physically active. These findings support the 
hypothesis of a vicious circle, where the overweight and obese people, often experiencing difficulties in walking, 
climbing stairs etc.,  are less inclined to become physically active, hence leading to an increase in weight, which in 
itself leads to less exercise (27). Therefore, implementing multimodal interventions, focussing both on exercise, diet, 
weight and psychosocial factors may be important in order to escape from the downward circle.  
Lower HRQoL scores were found in smokers compared to non smokers, both never smokers and former smokers. 
These results confirm the observations found in several studies conducted in the general population, however for 
coronary patients, conflicting results were found (8;12;14;15;17;17). Even though patients who made an attempt to 
quit smoking had a higher HRQoL compared to those who did not, no significant difference could be found between 
attempters and non attempters still smoking at interview, suggesting that only successful smoking cessation attempts 
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will lead to a HRQoL increase. Furthermore, our results imply that HRQoL outcomes rapidly improves once patients 
stopped smoking, because time since smoking cessation did not have an influence on HRQoL. Likewise a study in the 
general population by Piper et al. showed that HRQoL improved quickly (1 year) after smoking cessation and that this 
improvement was sustained for at least 3 years (8). Within the Nurses’ Health Study, HRQoL scores improved 
gradually with longer time since quitting (28). 
In complete agreement with past research both in the general population as well as in coronary patients, our results 
have shown that, based on both subjective as well as standardized measures (IPAQ), low physical activity levels are 
associated with worse HRQoL scores (16;29). Conform the observations made by Martin et al., our findings suggest 
that the improvements in HRQoL outcomes are associated with the amount of physical activity, however the largest 
increase was seen between low and moderate IPAQ scores and a significant but lower effect was found between 
moderate and high IPAQ (30). Both the actions related with an increase in physical activity as well as the actual 
physical activity levels were associated with better HRQoL outcomes. These components seem to reinforce one 
another, with the highest HRQoL scores seen in patients residing in the highest IPAQ class, who had moreover made 
an attempt to increase their physical activity. 
In accordance with the literature, BMI was inversely associated with HRQoL (13;15). In contrast, regarding weight 
changes (≥5% weight loss; -5% <weight change<+5%; ≥5% weight gain) between recruiting diagnosis and interview, no 
significant between group differences were observed. In the general population, similar results were found, allowing 
us to conclude that the act of exercising and healthy eating behaviour themselves, and not merely loosing weight, are 
aligned with a better HRQoL (30). Finally, dietary changes are associated with better HRQoL ouctomes. Results from 
the SUN project have also found an important association between adherence to Mediterranean diet (consumption of 
fruit, vegetables, fish an olive oil and reduction of meat an dairy intake) and better SF-36 scores (10). 
The limitations of our study have to be acknowledged in order to interpret the results correctly.  A potential for recall 
bias exists, since most data were self-reported. Patients included are not representative for countries’ coronary 
patients, since data from selected geographical areas were used. In addition, a cross-sectional study design was used, 
making it difficult to assess directionality of the association between HRQoL and lifestyle changes. Although 
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directionality is difficult to assess, the lack of association between the intention to take on a healthier lifestyle and 
patients’ HRQoL suggests that the lifestyle changes induce better HRQoL outcomes and not the other way round. It is 
unclear whether these benefits in HRQoL sustain over time or if the gains are associated with a onetime benefit 
inherent to the change itself, hence further research should focus on the long term gains in HRQoL. The main 
strengths of our study are its large sample, including patient across Europe and the ability to control for various 
confounders. 
Notwithstanding the limitations, out results reveal HRQoL gains associated with adopting a healthier lifestyle. The 
actual lifestyle changes - smoking cessation, increasing physical activity and adopting a healthy diet - and not the 
intention to change are associated with better HRQoL outcomes. Research has indicated that smokers may have 
concerns about the effect of smoking cessation on their weight, life satisfaction and HRQoL (31). Likewise, inactive or 
obese patients do not always see which benefits dietary and physical activity lifestyle changes could have. Doctors and 
other health care professionals should emphasise these improvements in patients’ quality of life in order to convince 
more patients to change their behaviour. Furthermore, these findings can be important for decision makers when 
setting the priorities related to their prevention policy. 
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Table 1: patient characteristics 
 Men (n=6523) Women (n=2222) All (n=8745) 
Age in years, Mean (SD) 62.3(9.5) 65.9(8.9) 63.2(9.5) 
Recruiting Diagnosis (%) 
CABG  
PTCA 
AMI  
Ischaemia 
 
20.6%(1343/6523) 
43.1%(2809/6523) 
19.1%(1248/6523) 
17.2%(1123/6523) 
 
17.1%(380/2222) 
35.3%(784/2222) 
20.7%(460/2222) 
26.9%(598/2222) 
 
19.7%(1723/8745) 
41.1%(3593/8745) 
19.5%(1708/8745) 
19.7%(1721/8745) 
Education (%) 
Primary education  
Secondary education  
High education  
 
22.5%(1459/6487) 
57.3%(3717/6487) 
20.2%(1311/6487) 
 
33.5%(740/2211) 
54.8%(1212/2211) 
11.7%(259/2211) 
 
25.3%(2199/8698) 
56.7%(4929/8698) 
18.1%(1570/8698) 
Diabetes (%) 22.6%(1461/6461) 29.9%(659/2207) 24.5%(2120/8668) 
History of stroke (%) 4.1%(268/6507) 5.7%(127/2216) 4.5%(395/8723) 
Recurrent CHD after recruiting diagnosis (%) 14.1%(912/6490) 11.4%(251/2208) 13.4%(1163/8698) 
At time of recruiting diagnosis 
BMI, Mean (SD) 
Obesity (%) 
Central obesity (%) 
Smoking (%) 
 
28.2(4.2) 
28.5%(789/2764) 
38.6%(468/1211) 
33.8%(2201/6508) 
 
28.87(4.84) 
36.1%(352/974) 
61.3%(284/463) 
19.6%(434/2215) 
 
28.3(4.4) 
30.5%(1141/3738) 
44.9%(752/1674) 
30.2%(2635/8723) 
At time of interview 
BMI, Mean (SD) 
Obesity (%) 
Central obesity (%) 
Smoking (%) 
Self reported PA 
No PA weekly (%) 
Light PA in most weeks (%) 
Vigorous PA, ≥20 min, once or twice/week (%) 
Vigorous PA, ≥20 min, ≥3 times a week (%) 
IPAQ moderate/high (%) 
Low 
Moderate 
high 
 
28.6(4.2) 
32.2%(2093/6500) 
41.6%(2681/6440) 
19%(1236/6507) 
 
10.8%(696/6428) 
56.3%(3618/6428) 
17.5%(1122/6428) 
15.4%(992/6428) 
 
22.3%(774/3476) 
38.8% (1350/3476) 
38.9%(1352/3476) 
 
29.70(5.19) 
44.8%(990/2210) 
70.4%(1546/2196) 
10.9%(242/2218) 
 
14.4%(316/2193) 
63.0%(1381/2193) 
13.3%(291/2193) 
9.3%(205/2193) 
 
31.9%(360/1129) 
39.1%(442/1129) 
29.0%(327/1129) 
 
28.9(4.5) 
35.4%(3083/8710) 
48.9%(4227/8636) 
16.9%(1478/8725) 
 
11.7%(1012/8621) 
58.0%(4999/8621) 
16.4%(1413/8621) 
13.9%(1197/8621) 
 
24.6%(1134/4605) 
38.9% (1792/4605) 
36.5% (1679/4605) 
Lifestyle advice on (%) 
Smoking cessation (in prior smokers) 
Diet 
Weight (if prior BMI>25)  
Physical activity 
 
88.3%(1935/2191) 
92.4%(5989/6479) 
75.7%(1607/2122) 
69.2%(4467/6457) 
 
84.5%(364/431) 
90.9%(2011/2213) 
80.5%(616/765) 
65.3%(1439/2204) 
 
87.7%(2299/2622) 
92.0%(8000/8692) 
77.0%(2223/2887) 
68.2%(5906/8661) 
Lifestyle changes to reduce risk of heart disease (%) 
Trying to stop smoking (in prior smokers) 
Trying to eat healthier 
Trying to increase physical activity 
 
81.2%(1713/2110) 
89.7%(5645/6291) 
59.9%(3792/6327) 
 
84.9%(348/410) 
91.6%(1963/2143) 
54.9% (1175/2142) 
 
81.8%(2061/2520) 
90.2%(7608/8434) 
58.6%(4967/8469) 
HRQoL at interview, Mean (SD) 
HADS-A 
HADS-D 
EQ-5Dindex 
EQ-VAS 
PCS-12 
MCS-12 
 
5.48(3.80) 
4.75(3.54) 
0.78(0.23) 
67.85(18.59) 
43.20(10.02) 
49.93(9.96) 
 
7.24(4.16) 
6.01(3.86) 
0.69(0.25) 
62.22(18.94) 
38.82(9.84) 
46.75(10.64) 
 
5.93(4.0) 
5.07(3.67) 
0.76(0.24) 
66.42(18.84) 
42.14(10.15) 
49.15(10.22) 
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Table 2: association between HRQoL and SMOKING CESSATION (adjusted mean (SE)) 
 HADS-A HADS-D EQ-VAS PCS-12 MCS-12 
COMPLETE SAMPLE      
Smoking history†      
Ever smoker (n=3058) 6.72(0.22) 5.68(0.22) 62.62(1.36) 38.52(0.78) 47.99(0.67) 
Prior smoker (n=1279) 6.73(0.24) 5.78(0.24) 62.26(1.41) 38.77(0.81) 48.05(0.71) 
Smoker (n=1478) 7.21(0.24) 6.48(0.24) 60.73(1.41) 37.81(0.80) 46.32(0.71) 
Never smoker (n=2896) 6.70(0.22) 5.85(0.22) 63.68(1.35) 39.58(0.77) 47.37(0.67) 
 p<0.000 p<0.001 p=0.003 p<0.001 p<0.001 
SMOKING AT TIME OF RECRUITING DIAGNOSIS      
Smoking cessation attempt       
Yes (n=2061) 7.01(0.34) 6.12(0.31) 62.11(1.64) 39.89(0.96) 46.84(0.93) 
No (n=459) 7.30(0.38) 6.54(0.34) 59.77(1.83) 38.41(1.05) 45.75(1.03) 
 p=0.160 p=0.030 p=0.018 p=0.004 p=0.054 
Smoking status at interview      
Still smoking – no cessation attempt (n=379) 7.32(0.38) 6.65(0.35) 60.61(1.85) 38.59(1.07) 45.38(1.05) 
Still smoking – cessation attempt (n=915) 7.38(0.34) 6.54(0.31) 60.91(1.68) 39.22(0.99) 45.69(0.95) 
Prior smoker† (n=1279) 6.83(0.34) 5.83(0.31) 62.22(1.65) 40.05(0.97) 47.38(0.93) 
 p=0.004 p<0.001 p=0.177 p=0.021 p<0.001 
PRIOR SMOKERS†      
Quit time       
<6 months before interview (n=173) 6.75(0.5) 6.00(0.45) 62.39(2.49) 39.60(1.34) 49.22(1.31) 
>6 months before interview (n=1077) 7.02(0.42) 6.15(0.38) 62.26(2.14) 40.48(1.17) 48.21(1.11) 
 p=0.392 p=0.620 p=0.930 p=0.264 p=0.303 
SMOKING AT THE TIME OF INTERVIEW      
Intention to quit smoking       
Yes (n=652) 7.70(0.50) 6.37(0.43) 59.07(2.20) 37.48(1.30) 45.22(1.36) 
No (n=354) 7.18(0.53) 6.25(0.46) 61.08(2.34) 38.67(1.38) 46.38(1.45) 
 p=0.064 p=0.629 p=0.120 p=0.073 p=0.126 
p-value adjusted for age, gender, diagnostic category, education, diabetes, recurrent CHD, history of stroke 
† Ever smoker=patients who have ever smoked but who where former smokers at the time of the recruiting diagnosis;  prior smoker= patients who where 
smoking at the time of the recruiting diagnosis, but were former smokers at the time of the interview; smoker= patients still smoking at the time of interview; 
never smokers= patients who have never smoked 
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Table 3: association between HRQoL and PHYSICAL ACTIVITY CHANGES (adjusted mean (SE)) 
 HADS-A HADS-D EQ-VAS PCS-12 MCS-12 
COMPLETE SAMPLE      
Attempt to increase physical activity      
Yes (n=4967) 6.57(0.22) 5.56(0.22) 64.17(1.33) 39.90(0.75) 48.02(0.66) 
No (n=3502) 7.14(0.22 6.31(0.22) 60.69(1.34) 37.50(0.75) 46.82(0.67) 
  p<0.001 p<0.001 p<0.001 p<0.001 p<0.001 
Physical activity level based on single question†      
No physical activity (n=1012) 7.62(0.24) 7.22(0.24) 55.53(1.43) 34.01(0.84) 44.93(0.70) 
Light physical activity in most weeks (n=4999) 6.83(0.22) 5.90(0.22) 62.53(1.34) 38.81(0.80) 47.57(0.64) 
Vigorous PA ≥20 min, ≤ 2x/week (n=1413) 6.20(0.24) 5.14(0.24) 67.21(1.41) 41.75(0.83) 47.71(0.69) 
Vigorous PA ≥20 min, ≥3x/week (n=1197) 6.02(0.24) 4.90(0.24) 68.36(1.43) 42.44(0.83) 49.33(0.70) 
 p<0.001 p<0.001 p<0.001 p<0.001 p<0.001 
IPAQ      
Low (n=1134) 7.21(0.29) 6.67(0.29) 57.21(2.09) 35.99(1.02) 46.20(0.86) 
Moderate (n=1792) 6.24(0.29) 5.48(0.29) 63.65(2.09) 39.64(1.02) 49.31(0.85) 
High (n=1679) 6.01(0.30) 5.09(0.29) 67.94(2.10) 41.03(1.03) 50.90(0.87) 
 p<0.001 p<0.001 p<0.001 p<0.001 p<0.001 
Change in physical activity according to IPAQ classes      
Change in PA + low IPAQ (n=515) 7.02(0.32) 6.49(0.31) 58.55(2.1) 37.57(1.03) 46.56(0.90) 
No change in PA + low IPAQ (n=591) 7.51(0.32) 6.95(0.31) 54.93(2.09) 33.90(1.03) 45.71(0.90) 
Change in PA + moderate/high IPAQ (n=2093) 5.90(0.30) 5.09(0.29) 66.74(2.01) 40.83(0.99) 50.23(0.84) 
No change in PA + moderate/high IPAQ (n=1264) 6.59(0.30) 5.66(0.30) 62.74(2.04) 38.82(1.00) 49.39(0.86) 
 p<0.001 p<0.001 p<0.001 p<0.001 p<0.001 
PHYSICALLY INACTIVE PATIENTS‡      
Intention to become PA (if normal weight)      
Yes (n=200) 7.32(0.49) 5.80(0.44) 63.63(2.43) 41.12(1.22) 47.04(1.25) 
No (n=736) 7.05(0.42) 6.30(0.38) 62.36(2.14) 37.87(1.07) 46.85(1.07) 
 p=0.399 p=0.096 p=0.409 p<0.001 p=0.834 
Intention to become PA (if overweight or obese)      
Yes (n=1098) 6.69(0.29) 6.00(0.26) 63.69(1.47) 39.10(0.82) 47.63(0.79) 
No (n=3315) 7.01(0.27) 6.28(0.25) 60.29(1.40) 37.65(0.79) 46.64(0.74) 
 p=0.025 p=0.035 p<0.001 p<0.001 p=0.009 
p-value adjusted for age, gender, educational level, recruiting diagnosis, diabetes, history of stroke and coronary recurring events 
†Which of the following four best describes your level of activity outside work?  
‡Physical inactive <3 to 5 x/week, 20 to 60 min/session 
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Table 4: association between HRQoL and DIETARY CHANGES (adjusted mean (SE)) 
 HADS-A HADS-D EQ-VAS PCS-12 MCS-12 
COMPLETE SAMPLE      
BMI at interview      
Normal (n=1572) 6.84(0.23) 5.92(0.23) 62.89(1.38) 39.45(0.78) 47.13(0.69) 
Overweight (n=4055) 6.68(0.22) 5.72(0.22) 63.53(1.34) 39.59(0.76) 47.80(0.66) 
Obese (n=3083) 6.90(0.22) 6.04(0.22) 61.89(1.34) 37.92(0.76) 47.39(0.66) 
 p=0.052 p=0.001 p=0.001 p<0.001 P=0.056 
Weight changes between recruiting diagnosis and interview      
≥5% weight loss (n=763) 6.78(0.26) 6.01(0.25) 62.87(1.55) 39.08(0.84) 46.91(0.76) 
-5% <weight change <+5% (n=1066) 6.66(0.23) 5.77(0.23) 63.23(1.45) 39.46(0.79) 47.61(0.69) 
≥5% weight gain (n=1496) 6.71(0.25) 5.95(0.24) 61.93(1.50) 38.56(0.82) 47.67(0.73) 
 p=0.746 p=0.115 p=0.070 p=0.012 p=0.209 
Attempt to eat healthier      
Change in fat intake      
Yes (n=7376) 6.77(0.22) 5.83(0.22) 62.94(1.33) 38.99(0.76) 45.57(0.65) 
No (n=1285) 6.99(0.24) 6.24(0.24) 61.04(1.42) 37.95(0.80) 47.02(0.70) 
 p=0.070 p<0.001 p=0.001 p=0.001 p=0.083 
Reduction in salt intake      
Yes (n=6150) 6.77(0.22) 5.79(0.22) 63.19(1.35) 39.08(0.76) 47.58(0.65) 
No (n=2417) 6.93(0.23) 6.08(0.23) 61.74(1.39) 38.44(0.78) 47.25(0.68) 
 p=0.108 p=0.001 p=0.002 p=0.010 p=0.202 
Increase in fish intake      
Yes (n=5818) 6.67(0.22) 5.73(0.22) 63.73(1.35) 39.12(0.76) 47.71(0.65) 
No (n=2815) 7.08(0.22) 6.21(0.23) 60.90(1.37) 38.33(0.77) 47.09(0.67) 
 p<0.001 p<0.001 p<0.001 p=0.001 p=0.012 
Increase in fruit and vegetable intake      
Yes (n=6765) 6.73(0.22) 5.78(0.22) 63.18(1.34) 39.10(0.76) 47.55(0.65) 
No (n=1886) 6.95(0.23) 6.19(0.23) 61.24(1.39) 38.32(0.79) 47.36(0.68) 
 p=0.034 p<0.001 p<0.001 p=0.003 p=0.492 
OVERWEIGHT AND OBESE PATIENTS      
Intention to lose weight      
Yes (n=3226) 6.90(0.23) 5.92(0.22) 62.21(1.33) 38.35(0.79) 47.66(0.68) 
No (n=3524) 6.78(0.23) 5.91(0.22) 62.31(1.33) 39.16(0.79) 47.39(0.68) 
 p=0.233 p=0.915 p=0.835 p=0.001 p=0.313 
p-value adjusted for age, gender, educational level, recruiting diagnosis, diabetes, history of stroke and coronary recurring events 
